scholarly article | Q13442814 |
P356 | DOI | 10.1002/14651858.CD010452 |
P50 | author | Buddha Basnyat | Q59774630 |
Christopher M Parry | Q91368884 | ||
P2093 | author name string | David Eyre | |
Nicole Stoesser | |||
P2860 | cites work | Typhoid fever | Q28216285 |
Global trends in typhoid and paratyphoid Fever | Q28267865 | ||
Typhoid and paratyphoid fever | Q28269252 | ||
A study of typhoid fever in five Asian countries: disease burden and implications for controls | Q33330938 | ||
Searching for the elusive typhoid diagnostic | Q33537360 | ||
Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004 | Q34092738 | ||
Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. | Q34275116 | ||
Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates from the United States | Q35191369 | ||
Typhoid fever and invasive nontyphoid salmonellosis, Malawi and South Africa | Q35806526 | ||
Resistance in gram-negative bacteria: enterobacteriaceae | Q36492668 | ||
Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study | Q36538683 | ||
Comparative yield of Salmonella typhi from blood and bone marrow cultures in patients with fever of unknown origin | Q37144378 | ||
Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi | Q39029190 | ||
Typhoid fever in the United States, 1999-2006. | Q40381702 | ||
An outbreak of peritonitis caused by multidrug-resistant Salmonella Typhi in Kinshasa, Democratic Republic of Congo | Q40398603 | ||
Extended-spectrum-beta-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines | Q40416931 | ||
Epidemiological shift, seasonal variation and antimicrobial susceptibility patterns among enteric fever pathogens in South India | Q40420077 | ||
Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. | Q40469776 | ||
Age-related clinical and microbiological characteristics of enteric fever in India. | Q40477070 | ||
Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae | Q40556003 | ||
A highly ceftriaxone-resistant Salmonella typhi in Bangladesh | Q40639739 | ||
Multidrug-resistant Salmonella typhi: a worldwide epidemic | Q40659638 | ||
Cancer mortality in chronic typhoid and paratyphoid carriers | Q40705950 | ||
Efficacy of Ciprofloxacin in the Treatment of Chronic Typhoid Carriers | Q40785775 | ||
Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area | Q40840867 | ||
Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime | Q44912723 | ||
The treatment of enteric fever. | Q55465441 | ||
Typhoid fever in the United States and antibiotic choice | Q82408488 | ||
P921 | main subject | paratyphoid fever | Q705906 |
P577 | publication date | 2013-03-28 | |
P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
P1476 | title | Treatment of enteric fever (typhoid and paratyphoid fever) with third and fourth generation cephalosporins |